Source link : https://www.newshealth.biz/health-news/expanded-treatment-options-for-primary-biliary-cholangitis-leave-open-questions/
The approval of ursodeoxycholic acid (UDCA) for primary biliary cholangitis (PBC) in 1997 marked a pivotal turning point in management of the condition, substantially reducing the risk of liver transplant and death. However, UDCA’s arrival was not a panacea for all patients with PBC. Up to 40% of patients with PBC won’t sufficiently respond to […]
Author : News Health
Publish date : 2024-11-30 15:00:00
Copyright for syndicated content belongs to the linked Source.
inHealth